SWOT Analysis
- S
- W
- O
- T
-
Strength (7)
Companies with no Debt
-
Weakness (3)
Stocks which have rising amounts of capital work in progress (CWIP), where costs of long term projects is rising
-
Opportunity (1)
FII / FPI or Institutions increasing their shareholding
-
Threats (0)
- Companies with no Debt
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
- Annual Net Profits improving for last 2 years
- Book Value per share Improving for last 2 years
- Companies with Zero Promoter Pledge
- FII / FPI or Institutions increasing their shareholding
Technical Analysis
Moving Averages
- 5 Day 1,458.4
- 10 Day 1,455.8
- 12 Day 1,455.4
- 20 Day 1,457.1
- 26 Day 1,458.9
- 50 Day 1,454.2
- 100 Day 1,420.2
- 200 Day 1,384.2
Current Price
- Bullish Moving Averages 7
- Bearish Moving Averages 9
Resistance and support
- First Resistance 1,483.9
- Second Resistance 1,513.2
- Third Resistance 1,531.4
- First Support 1,436.4
- Second Support 1,418.2
- Third Support 1,388.9
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
- CAGR IN 10 YEARS
- 23.36%
- 30.73%
- 34.75%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 1,545.66 | 1,454.51 | 1,236.56 | 1,113.99 | 924.60 |
|
| Operating Profit | 502.07 | 478.56 | 416.75 | 380.40 | 298.71 |
|
| OP Profit Margin | 32.48 | 32.90 | 33.70 | 34.15 | 32.31 |
|
| Interest | 75.14 | 73.68 | 59.33 | 55.09 | 52.80 |
|
| Profit After Tax | 250.02 | 237.59 | 214.89 | 205.89 | 142.29 |
|
| Cash Profit | 391.16 | 370.07 | 320.39 | 295.04 | 222.52 |
|
| EPS | 24.62 | 23.40 | 21.17 | 20.28 | 15.13 |
|
- CAGR IN 10 YEARS
- 21.51%
- 58.05%
- 32.34%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Equity | 101.56 | 101.55 | 101.50 | 101.50 | 105.00 |
|
| Reserve Surplus | 1,583.70 | 1,386.99 | 1,183.75 | 986.89 | 531.30 |
|
| TOT Debts | 801.36 | 734.36 | 734.70 | 538.29 | 547.70 |
|
| Gross Block | 2,195.78 | 1,973.54 | 1,693.03 | 1,259.08 | 1,095.50 |
|
| Capital Work In Progress | 79.13 | 28.36 | 19.92 | 22.81 | 5.76 |
|
| Cash Liquid Investment | 17.29 | 16.91 | 7.49 | 37.15 | 175.15 |
|
| Net Working Capital | 118.67 | 142.70 | 196.86 | 313.82 | 173.47 |
|
| Current Assets | 293.74 | 296.92 | 347.01 | 555.16 | 393.49 |
|
| Current Liabilities | 175.07 | 154.22 | 150.15 | 241.33 | 220.02 |
|
Jun 2026 (CR) |
Mar 2026 (CR) |
Dec 2025 (CR) |
Sep 2025 (CR) |
Jun 2025 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 410.55 | 408.06 | 394.35 | 408.50 | 334.75 |
|
| Gross Profit | 108.17 | 114.11 | 123.27 | 131.58 | 101.41 |
|
| Gross Profit Margins | 86.68 | 88.10 | 87.05 | 86.27 | 86.87 |
|
| Operating Profit | 114.66 | 127.40 | 130.68 | 140.72 | 99.52 |
|
| OP Profit Margin | 21.87 | 23.77 | 27.03 | 28.33 | 25.75 |
|
| Interest | 19.25 | 18.52 | 18.17 | 17.31 | 17.39 |
|
| Profit After Tax | 52.71 | 59.31 | 65.82 | 73.17 | 51.72 |
|
| Cash Profit | 90.34 | 94.96 | 100.65 | 106.35 | 84.31 |
|
| EPS | 5.20 | 5.85 | 6.48 | 7.20 | 5.09 |
|
- CAGR IN 10 YEARS
- 21.51%
- 58.05%
- 32.34%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| PE | 47.25 | 59.83 | 61.31 | 36.00 | 0.00 |
|
| P/BV | 6.99 | 9.55 | 10.25 | 6.81 | 0.00 |
|
| MCAP Sales | 7.64 | 9.77 | 10.65 | 6.65 | 0.00 |
|
| Asset Turnover | 0.65 | 0.68 | 0.68 | 0.79 | 0.86 |
|
| EV/EBITDA | 23.09 | 28.31 | 30.64 | 19.22 | 0.00 |
|
| DEBT/EQUITY | 0.48 | 0.53 | 0.54 | 0.63 | 0.93 |
|
| ROE | 15.74 | 17.13 | 18.11 | 24.03 | 26.10 |
|
| ROCE | 17.28 | 18.58 | 19.04 | 23.23 | 22.51 |
|
Quick Results Snapshot
Q1FY27 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.
Healthcare Facilities company Rainbow Childrens Medicare announced Q1FY27 results
Consolidated Financial Highlights:
- Revenue from operations reached Rs 4,699.85 million in Q1FY27, representing a growth of 33.17% compared to Rs 3,529.29 million in Q1FY26. On a QoQ basis, revenue increased by 2.19% from Rs 4,599.01 million in Q4FY26.
- Total income for Q1FY27 stood at Rs 4,826.95 million, an increase of 29.43% YoY from Rs 3,729.45 million in Q1FY26 and a growth of 3.81% QoQ from Rs 4,649.65 million in Q4FY26.
- Profit before tax for Q1FY27 was reported at Rs 839.53 million, up 17.62% YoY from Rs 713.74 million in Q1FY26, while declining by 3.27% sequentially compared to Rs 867.91 million in Q4FY26.
- Net profit for the period was Rs 625.40 million in Q1FY27, showing a YoY growth of 16.23% from Rs 538.05 million in Q1FY26. On a QoQ basis, net profit registered a decrease of 20.04% compared to Rs 782.18 million in Q4FY26.
- Earnings per share (Basic) for the quarter stood at Rs 5.97, compared to Rs 5.27 in Q1FY26 and Rs 7.59 in Q4FY26.
Standalone Financial Highlights:
- Revenue from operations for Q1FY27 was Rs 4,105.47 million, reflecting a YoY growth of 22.64% from Rs 3,347.48 million in Q1FY26 and a marginal QoQ growth of 0.61% from Rs 4,080.64 million in Q4FY26.
- Total income for the quarter stood at Rs 4,233.04 million, up 19.57% YoY from Rs 3,540.33 million in Q1FY26 and up 2.42% QoQ from Rs 4,133.04 million in Q4FY26.
- Net profit for Q1FY27 reached Rs 527.06 million, a growth of 1.91% YoY compared to Rs 517.20 million in Q1FY26. Sequentially, net profit declined by 11.13% from Rs 593.05 million in Q4FY26.
- Earnings per share (Basic) was Rs 5.20 in Q1FY27, compared to Rs 5.09 in Q1FY26.
Business Highlights:
- Segment wise Performance: The company is primarily engaged in a single business segment of rendering medical and healthcare services. Furthermore, business operations are concentrated within India, representing a single geographical segment.
- New Hospital Development: Subsequent to the quarter end, the company executed definitive transaction documents for capacity addition through the development of a new children and women's hospital at Malad, Mumbai. This project is being managed through its wholly owned subsidiary, Rainbow Women & Children's Hospital Private Limited.
- Strategic Acquisition: The company has executed a Partnership Interest and Contribution Transfer Agreement (PICTA) to acquire a 64% partnership interest in Super Prime Medical Care LLP for an aggregate consideration of Rs 198 million. This acquisition involves a running children's hospital at Nellore, Andhra Pradesh, and is expected to be completed in the quarter ended September 30, 2026.
- Corporate Designation: Mr. Anshuman Jaiswal was elevated from the position of Group Head – Legal to Chief Legal Officer and designated as Senior Management Personnel (SMP) of the company effective July 30, 2026.
- Dividend Payout: A final dividend for FY26 of Rs 3.50 per equity share, aggregating to Rs 355.48 million, was approved by shareholders at the AGM and paid on July 29, 2026.
- Stock Options: The company allotted 7,483 equity shares during Q1FY27 following the exercise of stock options under the Employee Stock Unit Plan 2023. Additionally, 267,550 stock options were granted under the ESOP 2025 scheme in May 2026 to eligible employees.
Stocks Comparison
Table
Chart
Company name |
LTP |
Market cap (Cr) |
Return (1Y %) |
Risk (Std. Dev.) |
PE Ratio |
Financial Year |
|---|---|---|---|---|---|---|
| Rainbow Childrens Medicare Ltd | 1,454.70 | 14,774.90 | -0.16 | 0.07 | 50.88 | Mar 2026 |
| Apollo Hospitals Enterprise Ltd | 8,944.50 | 128,608.19 | 13.39 | 0.05 | 58.06 | Mar 2026 |
| Max Healthcare Institute Ltd | 1,049.30 | 102,129.44 | -9.06 | 0.09 | 70.47 | Mar 2026 |
| Fortis Healthcare Ltd | 886.00 | 66,889.29 | -7.96 | 0.09 | 61.71 | Mar 2026 |
| Aster DM Quality Care Ltd | 755.05 | 65,815.63 | 22.91 | 0.08 | 181.69 | Mar 2026 |
| Global Health Ltd | 1,499.40 | 40,314.63 | 8.85 | 0.09 | 73.36 | Mar 2026 |
| Narayana Hrudayalaya Ltd | 1,928.50 | 39,410.98 | 6.72 | 0.07 | 48.29 | Mar 2026 |
| Krishna Institute of Medical Sciences Ltd | 809.85 | 34,014.23 | 9.00 | 0.11 | 175.16 | Mar 2026 |
| Dr Lal Pathlabs Ltd | 1,896.90 | 31,839.24 | 16.33 | 0.08 | 58.24 | Mar 2026 |
| Poly Medicure Ltd | 1,726.00 | 17,494.99 | -13.55 | 0.14 | 55.97 | Mar 2026 |
| Vijaya Diagnostic Centre Ltd | 1,558.90 | 16,056.31 | 48.48 | 0.12 | 85.58 | Mar 2026 |
| Dr Agarwals Health Care Ltd | 500.45 | 15,865.58 | 13.98 | 0.09 | 85.58 | Mar 2026 |
| Syngene International Ltd | 369.05 | 14,897.41 | -43.33 | 0.11 | 67.50 | Mar 2026 |
| Indegene Ltd | 600.10 | 14,457.89 | 2.44 | 0.09 | 35.91 | Mar 2026 |
| Metropolis Healthcare Ltd | 597.45 | 12,394.33 | 16.55 | 0.07 | 61.10 | Mar 2026 |
| Yatharth Hospital & Trauma Care Services Ltd | 1,139.50 | 10,979.58 | 42.47 | 0.15 | 62.99 | Mar 2025 |
| Healthcare Global Enterprises Ltd | 708.25 | 10,574.33 | 6.08 | 0.09 | 317.78 | Mar 2026 |
| Jupiter Life Line Hospitals Ltd | 280.05 | 9,180.88 | -4.31 | 0.08 | 48.89 | Mar 2026 |
| Thyrocare Technologies Ltd | 555.80 | 8,846.41 | 37.98 | 0.12 | 50.31 | Mar 2026 |
| Indraprastha Medical Corporation Ltd | 362.90 | 3,326.81 | -24.52 | 0.15 | 17.69 | Mar 2026 |
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Announcement Under Regulation 30 - Update On Commencement Of Operations At Guntur Andhra Pradesh.
Sep 16, 2026Update on Commencement of Operations at Guntur Andhra Pradesh.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sep 11, 2026Intimation of Schedule of Analyst/Institutional Investor Group Meetings.
Rainbow Childrens Medicare Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Sep 11, 2026Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings.
Announcement under Regulation 30 (LODR)-Cessation
Aug 31, 2026Resignation of Senior Management Personnel.
Rainbow Childrens Medicare Limited - Resignation
Aug 31, 2026RAINBOW: Rainbow Children`s Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026.
Rainbow Childrens Medicare Limited - Resignation
Aug 25, 2026Rainbow Childrens Medicare Limited has informed the Exchange regarding Resignation of Mr Vikas Maheshwari as Chief Financial Officer of the company w.e.f. August 31, 2026.
Announcement under Regulation 30 (LODR)-Change in Management
Aug 25, 2026Resignation of Mr. Vikas Maheshwari as Chief Financial Officer of the Company w.e.f. August 31 2026
| Ex-Date | Purpose | Notes |
|---|---|---|
| 2026-07-30 | Quarterly Results | |
| 2026-05-23 | Audited Results, Final Dividend & A.G.M. | |
| 2026-01-28 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-07-26 | Quarterly Results | |
| 2025-05-24 | Audited Results, Final Dividend & A.G.M. | |
| 2025-02-09 | Quarterly Results & Others | To consider other business matters. |
| 2024-10-27 | Quarterly Results | |
| 2024-08-13 | Quarterly Results | |
| 2024-05-19 | Audited Results & Final Dividend | |
| 2024-01-24 | Quarterly Results | |
| 2023-10-30 | Quarterly Results | |
| 2023-08-07 | Quarterly Results | |
| 2023-05-14 | Audited Results & Final Dividend | |
| 2023-02-09 | Quarterly Results | |
| 2022-11-03 | Quarterly Results | |
| 2022-08-08 | Quarterly Results | |
| 2022-05-27 | Audited Results & Final Dividend |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 2026-07-21 | 3.5 | FINAL | 2026-07-21 | Equity Share |
| 2025-06-27 | 3 | FINAL | 2025-06-28 | Equity Share |
| 2024-07-23 | 3 | FINAL | 2024-07-23 | Equity Share |
| 2023-06-22 | 3 | FINAL | 2023-06-22 | Equity Share |
| 2022-09-07 | 2 | FINAL | 2022-09-08 | Equity Share |
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
Client name |
Deal Type |
Date |
Action |
Avg. price |
Quantity |
Exchange |
|---|---|---|---|---|---|---|
| Bnp Paribas Arbitrage | Bulk | 2023-09-15 |
Purchase |
1,025.22 | 1,568 | NSE |
| Bnp Paribas Arbitrage | Bulk | 2023-09-15 |
Sell |
1,023.22 | 655,246 | NSE |
| Stichting Depositary Apg Emerging Markets Equity Pool | Bulk | 2022-12-05 |
Purchase |
735.00 | 1,511,300 | NSE |
| Government Of Singapore | Bulk | 2022-12-05 |
Purchase |
735.00 | 1,446,185 | NSE |
| Icici Prudential Mutual Fund | Bulk | 2022-12-05 |
Purchase |
735.00 | 1,253,750 | NSE |
| Abu Dhabi Investment Authority | Bulk | 2022-12-05 |
Purchase |
741.25 | 900,000 | NSE |
| Stichting Depositary Apg Emerging Markets Equity Pool | Bulk | 2022-12-05 |
Purchase |
735.00 | 745,200 | NSE |
| India Acorn Icav - Ashoka India Opportunities Fund | Bulk | 2022-12-05 |
Purchase |
735.00 | 722,000 | NSE |
| Government Of Singapore | Bulk | 2022-12-05 |
Purchase |
735.00 | 664,500 | NSE |
| Icici Prudential Mutual Fund | Bulk | 2022-12-05 |
Purchase |
735.00 | 516,250 | NSE |
| Cdc Group Plc | Bulk | 2022-12-05 |
Sell |
735.55 | 9,632,876 | NSE |
| Cdc India Opportunities Limited | Bulk | 2022-12-05 |
Sell |
735.00 | 5,033,236 | NSE |
Client name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Avg. Price |
Regulation (Insider/SAST) |
Mode |
|---|---|---|---|---|---|---|---|---|
| White Oak Capital Management Consultants Llp | Other |
Disposal |
2026-05-22 | 2,038,948 | 2,845,567 | SAST 29(2) | Others | |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2024-11-06 | 10,000 | 406,379 | 1,568.20 | Insider Trading | Market Sale |
| Dr. Prashanth K | Designated Person |
Disposal |
2024-11-06 | 10,000 | 10,030 | 1,603.98 | Insider Trading | Market Sale |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2024-09-30 | 5,000 | 416,379 | 1,430.64 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2024-09-20 | 3,500 | 1,154,106 | 1,352.02 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2024-09-19 | 15,600 | 1,157,606 | 1,307.33 | Insider Trading | Market Sale |
| Dr. Shruthi Reddy Poddutoor | Designated Person |
Disposal |
2024-09-19 | 15,000 | 15,000 | 1,325.95 | Insider Trading | Market Sale |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2024-09-17 | 5,000 | 421,379 | 1,335.02 | Insider Trading | Market Sale |
| Vikas Maheshwari | KMP |
Acquisition |
2024-08-28 | 5,986 | 5,986 | 10.00 | Insider Trading | ESOP |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2024-08-21 | 19,716 | 426,379 | 1,184.91 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2024-08-21 | 7,000 | 1,173,206 | 1,195.55 | Insider Trading | Market Sale |
| Sanjeev Sukumaran | KMP |
Acquisition |
2024-07-22 | 44,000 | 44,000 | 10.00 | Insider Trading | ESOP |
| Kancharla Family Trust (Through Dr. Ramesh Kancharla) | Promoter Group |
Acquisition |
2024-05-29 | 26,500 | 5,205,700 | 1,235.25 | Insider Trading | Market Purchase |
| Dr. Ramesh Kancharla | Promoter & Director |
Acquisition |
2024-05-29 | 22,777 | 31,517,431 | 1,225.43 | Insider Trading | Market Purchase |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2024-03-30 | 4,000 | 446,095 | 1,250.77 | Insider Trading | Market Sale |
| Maddirala Subrahmanyam | Immediate Relative |
Disposal |
2024-03-05 | 800 | 700 | 1,407.89 | Insider Trading | Market Sale |
| Varikutti Madhu Babu | Designated Person |
Disposal |
2024-02-23 | 4,500 | 500 | 1,259.65 | Insider Trading | Market Sale |
| White Oak Capital Management Consultants Llp | Other |
Disposal |
2023-09-13 | 2,088,635 | 5,824,215 | SAST 29(2) | Market | |
| Kalyani Nulu | Designated Person |
Disposal |
2023-08-25 | 2,270 | 0 | 1,147.09 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2023-06-24 | 5,066 | 1,180,206 | 975.18 | Insider Trading | Market Sale |
| R Gowrisankar | Designated Person |
Disposal |
2023-06-21 | 1,500 | 39,040 | 966.00 | Insider Trading | Market Sale |
| Mahesh Madduri | Designated Person |
Disposal |
2023-06-08 | 49,000 | 1,000 | 928.02 | Insider Trading | Market Sale |
| Saurabh Anand Bhandari | Designated Person |
Disposal |
2023-06-08 | 9,750 | 250 | 938.15 | Insider Trading | Market Sale |
| Varikutti Madhu Babu | Designated Person |
Disposal |
2023-05-22 | 1,340 | 5,200 | 921.69 | Insider Trading | Market Sale |
| Ranjini Nair | Designated Person |
Disposal |
2023-05-22 | 10,000 | 216 | 923.41 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2023-03-23 | 4,000 | 1,185,272 | 740.69 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2023-03-07 | 1,900 | 1,189,272 | 739.84 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2023-03-02 | 5,400 | 1,191,172 | 729.11 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2023-02-24 | 2,627 | 1,196,572 | 755.56 | Insider Trading | Market Sale |
| Dr. Shaik Farhan Abdur Rashid | Designated Person |
Disposal |
2023-02-20 | 6,202 | 394,256 | 768.00 | Insider Trading | Market Sale |
| Varikutti Madhu Babu | Designated Person |
Disposal |
2023-02-20 | 2,000 | 6,540 | 761.91 | Insider Trading | Market Sale |
| Dr. Preetham Kumar Poddutoor | Designated Person |
Disposal |
2023-02-20 | 2,100 | 1,199,199 | 770.68 | Insider Trading | Market Sale |
| White Oak Capital Management Consultants Llp | Other |
Acquisition |
2022-12-09 | 3,285,988 | 7,912,850 | SAST 29(2) | Market | |
| British International Investment Plc & Cdc India Opportunities Ltd | Other |
Disposal |
2022-12-09 | 14,666,112 | SAST 29(2) | Market | ||
| Varikutti Madhu Babu | Designated Person |
Disposal |
2022-11-18 | 2,000 | 8,540 | 871.45 | Insider Trading | Market Sale |
| Jayadeep Reddy Jammuladinne | Designated Person |
Disposal |
2022-11-18 | 3,918 | 0 | 865.97 | Insider Trading | Market Sale |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2022-11-16 | 10,000 | 450,095 | 819.42 | Insider Trading | Market Sale |
| Jayadeep Reddy Jammuladinne | Designated Person |
Disposal |
2022-11-14 | 3,000 | 3,918 | 849.40 | Insider Trading | Market Sale |
| Dr. Maddirala Subrahmanyam | Immediate Relative |
Disposal |
2022-11-14 | 15,000 | 0 | 794.06 | Insider Trading | Market Sale |
| Dr. Pranathi Subrahmanyam Maddirala | Designated Person |
Disposal |
2022-11-14 | 40,500 | 460,095 | 843.63 | Insider Trading | Market Sale |
About Rainbow Childrens Medicare Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Rainbow Childrens Medicare Limited was originally incorporated as `Rainbow Children`s Medicare Private Limited` as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana. Subsequently, the Company converted into a Public Limited, and name of the Company was changed to `Rainbow Children`s Medicare Limited` via fresh Certificate Incorporated issued by the RoC on November 20, 2021. The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 23 hospitals and 5 outpatient clinic centers across 9 cities, with a total bed capacity of 2,375 beds. The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services. Its Pediatric Services include newborn and pediatric intensive care, pediatric multi-specialty services, pediatric Quaternary care (including multi-organ transplants); whereas, Obstetrics & Gynecology services include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility treatment. Rainbow has been pivotal in saving thousands of children. Its inpatient specialties for child care includes Neonatology, Pediatric Intensive Care, Neonatal Intensive Care, Neurology, Gastroenterology, Nephrology, Hematology and Oncology, Pediatric Surgery, Cardiology and Nutrition. The Company was founded on a model of full-time, exclusive doctor led, 24/7 pediatric healthcare delivery, and a significant number of doctors have experience with this same model while training in other countries such as the United Kingdom, United States, Canada and Australia. It also established robust patient retrieval services in and around Hyderabad to retrieve neonates and children from nearby districts to the hub hospital in Hyderabad. Apart from this, the Company follow a doctor engagement model whereby, most of the core specialists work exclusively at hospitals on a full-time retainer basis. This model ensures that most of core specialists are available 24/7 at the hospitals, which is particularly important for children`s emergency, neonatal and pediatric intensive care services. Rainbow Children`s Hospital and BirthRight by Rainbow is an exclusive woman and child care hospital with a nationwide footprint. Its full-spectrum, consultant-led woman and child care services are driven by 22 years of experience and have transformed the lives of women and children across the cities of Hyderabad, Vijayawada, Bengaluru, Delhi, Chennai, and Visakhapatnam. In 1999, Dr. Ramesh Kancharla, the founding Promoter of the Company established first pediatric specialty hospital in 1999 with a 50-bed pediatric hospital in Hyderabad, to address the opportunity to provide pediatric healthcare in the City of Hyderabad. The aim was to provide comprehensive neonatal, pediatric intensive care and pediatric sub-specialty services to children. Since then, under the leadership of Dr. Ramesh Kancharla, Founding Promoter, it established reputation as a leader in multi-specialty pediatric services, with strong clinical expertise in managing complex diseases. The Company has also expanded its operations to include obstetrics and gynecology services, whereby it offer comprehensive perinatal services to patients. In 2005, the Company expanded Banjara Hills Facility to Pediatric Tertiary Care Centres. In 2007, the Company established Hospital at Vijayawada. It started perinatal services by providing comprehensive perinatal care which was backed by teamwork, round the clock availability of obstetricians, anesthesiologists, neonatologists and maternal intensive care services. In 2009, the Company established Hospital at Vikrampuri. In 2010, the Company inaugurated Opening of outpatient clinic at Madhapur. It established IVF hub at Madhapur and hospital at Kondapur. In 2015, the Company established hospitals at Hydernagar and Marathalli respectively. In 2016, the Company established Hospitals at Bangalore and Hyderabad. In 2017, Madhukar Rainbow Hospital at New Delhi commenced operations. In 2018, the Company established Hospital at Guindy, in Chennai. During the year 2019, the Company started outpatient and IVF facility at Kondapur. It commenced commenced providing pediatric Quaternary Care Services at Banjara Hills in Hyderabad. In 2020, the Company established hospitals at Bengaluru and Vizag. In May 2021, the Company moved from an old facility to a new facility for its hospital at Vikrampuri, in Hyderabad. During 2021-22, the Company came out with an Initial Public Offering aggregating 29,168,579 Equity Shares, by issuing 51,67,679 Equity Shares through a fresh issue and 24,000,900 Equity Shares through offer for sale. The IPO comprised of raising capital Rs 280 Crore through fresh issue and Rs 1300 crore through offer for sale, which completed in April, 2022 and resulting to this, the Equity Shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited effective May 10, 2022. In 2022, the Company started Organ Transplantation work at its Hyderabad Hub. In 2023, the Company inaugurated inaugurated a new hospital with 100 beds in the Financial District of Hyderabad, as well as a 55-bed hospital in Sholinganallur (OMR), Chennai. A brownfield spoke hospital with approximately 80 beds was acquired in Sarjapur, Bengaluru in FY23. The Company commissioned 3 new spoke hospitals including Himayatnagar, Hyderabad; Sarjapur in Bengaluru and Anna Nagar in Chennai in FY24. It expanded 2 existing hospitals by adding a new block at its Hydernagar Hospital in Hyderabad. Further, it established an outpatient clinic at Hennur, Bengaluru. It launched IVF services at 8 hospitals, taking the count to 11 in 2024. In 2025, Company has purchased two new land parcels admeasuring 9,391 Sq Mtr (~2.32 acres) and 4,987.10 Sq Mtr (~1.23 acres), situated in Sector 44 and Sector 56 respectively in Gurugram, Haryana, for setting up two hospitals with a total bed capacity of ~400 beds. Overall, a total of 280 beds were added during FY 2024-25. In FY2025-26, Company acquired Prashanthi Hospital, Warangal in July 2025. It acquired the Pratiksha Hospital, Guwahati with the expansion into Northeast region. It commenced business at the Rajahmundry Hospital across the Coastal Andhra Pradesh. 60 Beds hospital at HRBR, Bengaluru, commenced operations on May 1, 2026. Mahadevpura IVF clinic commenced operations from May 1, 2026. The Company added 440 beds during the year 2026 across the key markets.
Rainbow Childrens Medicare share price as on 21 Sep 2026 is Rs. 1454.7. Over the past 6 months, the Rainbow Childrens Medicare share price has increased by 29.02% and in the last one year, it has decreased by 0.16%. The 52-week low for Rainbow Childrens Medicare share price was Rs. 1084 and 52-week high was Rs. 1610.
8-2-120/103/1 Survey No 403, Road No 2 Banjara Hills, Hyderabad, Telangana, 500034
Tel No. 91-40-49695244
Email companysecretary:rainbowhospitals.in
Independent Non Exe. Director
Independent Non Exe. Director
Non Executive Director
Independent Non Exe. Director
Independent Non Exe. Director
Company Sec. & Compli. Officer
Chairman / Executive Director / M D / Promoter
WTD & Executive Director
543524
RAINBOW
INE961O01016
Jul
Rainbow Childrens Medicare Ltd FAQs
You can buy Rainbow Childrens Medicare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Rainbow Childrens Medicare Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Sep 18, 2026 03:56 PM the closing price of Rainbow Childrens Medicare Ltd was Rs.1,454.70.
The latest PE ratio of Rainbow Childrens Medicare Ltd as of Sep 18, 2026 03:56 PM is 50.88
The latest PB ratio of Rainbow Childrens Medicare Ltd as of Sep 18, 2026 03:56 PM is 8.85
The 52-week high of Rainbow Childrens Medicare Ltd share price is Rs. 1,610.00 while the 52-week low is Rs. 1,084.00
According to analyst recommendations, Rainbow Childrens Medicare Ltd Share has a "Buy" rating for the long term.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 18, 2026 03:56 PM, the market cap of Rainbow Childrens Medicare Ltd stood at Rs. 14,773.79 Cr.